September 27, 2024

Real-World Data Offering from Proscia: Empowering Life Sciences to Advance Precision Medicine Pipelines

From the Proscia blog: Following a successful year-long pilot with a subset of our biopharma and biotech partners, today we announced that life sciences organizations can now leverage Proscia’s real-world data offering on the Concentriq® platform to...

recent articles

NIJMEGEN, The Netherlands--(BUSINESS WIRE)--Aiosyn, a software company that develops AI-powered pathology software, has announced the integration of its AI-powered automated quality control (QC) algorithm in the Sectra Amplifier Marketplace....

The New York State Department of Health has approved Cayuga Health System to use a Smart In Media PathoZoom LiveView laboratory-developed test (LDT) image-based method for digital slide sharing -  Rapid On Site Evaluation (ROSE) in fine needle...

Xtalks: Featured speaker from Proscia will share real-world examples and use cases during free event. TORONTO, ONTARIO, CANADA (PRWEB) MAY 01, 2023 Preclinical research and development (R&D) centers around workflows that generate more...

Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development 27 April 2023 at 12:00 a.m. EEST. Aiforia has received a funding...

Exeter, England, April 19th 2023 — Diagnexia UK Limited, owned by Deciphex, is the UK's fastest-growing pathology diagnostics service provider. Today, the company proudly celebrated the launch of its expanded facility at Exeter Science Park....

PathAI and ConcertAI: Researchers derive novel insights through the combination of PathAI's proprietary tumor microenvironment features with ConcertAI's multi-modal clinical data BOSTON, April 25, 2023 /PRNewswire/ -- PathAI, a global...

OR

platinum partners

gold partners

Silver Partners

Media Partners